
Open: This is "Face the Nation," November 29
Today on "Face the Nation," preparations to distribute the yet-to-be-approved coronavirus vaccine pick up speed as America braces for the fallout from the Thanksgiving holiday
Watch CBS News
Today on "Face the Nation," preparations to distribute the yet-to-be-approved coronavirus vaccine pick up speed as America braces for the fallout from the Thanksgiving holiday
Doctors and public health officials fear the nation could see another sharp increase in coronavirus cases. The concerns come as virus-related infections and deaths continue to hit record highs. Dr. Shereef Elnahal, the president and CEO of University Hospital in Newark, New Jersey, joins CBSN to discuss.
As coronavirus cases in the U.S. spike to record highs, the Centers for Disease Control and Prevention are considering a change to the agency's recommendation about quarantining for 14 days after a person tests positive for coronavirus. Dr. Wilbur Chen-- a professor at the University of Maryland School of Medicine, the director of the UMB Travel Medicine Practice and the chief of adult clinical studies at the Center for Vaccine Development and Global Health -- joins CBSN to discuss the latest developments for a possible coronavirus vaccine and the CDC's approach to vaccine guidelines.
More than 2,100 COVID-19 deaths were reported in the U.S. on Tuesday, making it the deadliest day the country has seen in six months. The virus continues to hit hard in America's heartland. "CBS This Morning" lead national correspondent David Begnaud reports from Fargo, North Dakota, and Dr. Leo Nissola, an immunotherapy researcher, joined CBSN to discuss the latest on a vaccine.
CBS News got rare access inside Jackson Memorial Hospital in Miami that will be among the first to receive Pfizer's coronavirus vaccine. Mireya Villarreal shows us how health care workers are preparing for its distribution.
The AstraZeneca vaccine created with Oxford University is another sign of hope for the world as cases and hospitalizations run rampant. Dr. Amesh Adalja joins CBSN to discuss both the vaccine and an antibody treatment approved by the FDA.
A record 87,000 Americans tested positive for the coronavirus on Thursday, and more than 250,000 American have died since the pandemic began. On Friday, Pfizer applied for emergency authorization for its coronavirus vaccine, which could go into distribution by the end of the year. Dr. John Moore. professor of microbiology and immunology at Weill Cornell Medical College at Cornell University, joined CBSN to discuss the latest.
Missed the second half of the show? The latest on the coronavirus vaccine and withdrawal of U.S. troops from Afghanistan.
While two major drug companies await approval from the FDA on their coronavirus vaccines, behind the scenes, they're drawing up plans to store, ship and distribute the doses. "CBS This Morning Saturday" co-host Dana Jacobson shares how vaccine companies face some icy challenges.
Progress is quickly being made in the race for a coronavirus vaccine. AstraZeneca says the vaccine it is developing at Oxford University in London is highly effective in older adults. This is the third vaccine to show promise in recent weeks, and it could be available alongside the vaccines being developed by Pfizer and Moderna. Charlie D'Agata discusses how the AstraZeneca vaccine differs from the other two.
Country music legend Dolly Parton is getting praise for her $1 million donation toward coronavirus vaccine research at Vanderbilt University, which was involved in trials for the Moderna vaccine.
Moderna says their COVID vaccine highly successful; FBI: massive rise in hate crimes in 2019
Moderna says it has developed a coronavirus vaccine that's nearly 95% effective, and with emergency approval from the FDA it could start distributing the shots to high-risk patients and health care workers as soon as December. Dr. Jon LaPook reports.
Doctors are warning that a surge in coronavirus cases in the U.S. could overwhelm hospitals. CBS News correspondent Carter Evans joins CBSN AM to explain how they're preparing.
White House officials refuse to meet with President-elect Joe Biden or assist his transition team, as President Trump continues to push unfounded claims of voter fraud. But Biden is still moving forward with plans to deal with the pandemic, economy, immigration and climate change. CBS News' Michael George reports on the latest, and then CBS News correspondent Nikole Killion joins CBSN's Lana Zak to discuss where things stand.
The U.S. shattered its third consecutive record for daily coronavirus cases on Friday. All 50 states are now reporting a rise in daily cases as President Trump says his administration won't propose a nationwide lockdown. Dr. Amesh Adalja, an infectious disease expert, joins CBSN with more on the fight against coronavirus.
The U.S. recorded a record-breaking 153,000 newly confirmed cases of COVID-19 nationwide yesterday. Some hospitals are reporting a shortage in staffing, beds and personal protective equipment. Dr. Uzma Syed, an infectious disease specialist at the Good Samaritan Hospital Medical Center on Long Island, joins CBSN to discuss the fight against the pandemic.
President Trump said Friday that a COVID-19 vaccine could be distributed widely by April, but he said delivery to New York could be delayed due to Governor Andrew Cuomo's comments. Watch his remarks.
Melissa Armo, founder and owner of Stock Swoosh, joins CBSN to discuss how the outcome of the presidential election and news about progress towards a COVID-19 vaccine could affect the stock market.
Dr. Anthony Fauci said vaccines will likely be available for most Americans who want it by April. In CBS News' series "Racing to a Cure," David Martin takes a look at what it will take to distribute those first doses.
Drugmaker Pfizer said its coronavirus vaccine trials are 90% effective. Meanwhile, President-elect Joe Biden announces new COVID-19 plans for the country as the U.S. surpasses 10 million confirmed cases. Internal medicine specialist and immunologist Dr. Neeta Ogden joins CBSN's Elaine Quijano to discuss the latest news about the pandemic.
Investors cheered by positive vaccine trial and growing political certainty following U.S. presidential election.
More than 40 states are reporting an increase in COVID-19 cases and many parts of the Midwest are seeing record hospitalizations. Hospitals are also being warned about the threat of ransomware attacks. Yahoo News medical contributor and ER doctor Dara Kass joined CBSN with medical insight on the pandemic.
New coronavirus cases in the U.S. hit record highs over the weekend, and hospitalizations are also on the rise in large areas of the country. Emergency care physician Dr. Ron Elfenbein joins CBSN to discuss the latest on the pandemic.
The Food and Drug Administration approved the antiviral drug remdesivir to treat adults who are hospitalized with COVID-19, although it has not been proven to reduce deaths. Dr. Bob Lahita joins CBSN to discuss that plus the latest developments in the race for a vaccine as coronavirus cases spike around the world.
"We have a framework for a TikTok deal," Treasury Secretary Scott Bessent said after talks with Chinese officials in Spain.
Vance has described his longtime friendship with Kirk, who was also a key ally in his political rise.
CBS News looked at the cost of producing coal, gas, nuclear, wind and solar energy to determine which is the cheapest.
As Trump urges Israel to be "very careful" after a strike in U.S.-allied Qatar, Netanyahu calls Rubio's visit "a clear message that America stands with Israel."
CBS News Atlanta makes its debut with immersive technology, a startup-style newsroom and a mission to serve the community from day one.
President Trump says getting rid of a quarterly reporting requirement for public companies would lower costs and help businesses.
The suspect in the assassination of Charlie Kirk is under special watch in a Utah jail, days after he allegedly shot and killed the 31-year-old conservative activist.
A range of companies and other organizations are sanctioning — and sometimes firing — workers over their public comments about Charlie Kirk. They may have little recourse.
Maurene Comey is suing the Trump administration over her firing in July, saying that her termination was unlawful and unconstitutional.